Admission Date:  [**2101-11-4**]     Discharge Date:  [**2101-11-10**]

Date of Birth:   [**2066-2-26**]     Sex:  M

Service:  Medicine
HISTORY OF PRESENT ILLNESS:  The patient is a 35 year old
male with a history of asthma who presented to the Emergency
Room on [**2101-11-4**] with shortness of breath.  In the
past, the patient had been hospitalized for his asthma one
previous time, during which admission he required intubation.
The patient notes that his current shortness of breath began
the previous evening while he was at home television.  He
felt a little tight, however, his asthma was unresponsive to
multiple albuterol meter dose inhalers.  The following
morning, was brought by ambulance to the Emergency Room.

The patient was admitted to the Medical Intensive Care Unit
hours as well as albuterol nebulizers as needed for his
asthma.  He was also given magnesium sulfate and 0.3 mg of
subcutaneous epinephrine as well as hydrochlorothiazide for
his hypertension.

PAST MEDICAL HISTORY:  1.  Asthma since childhood; on
questioning, patient notes that he was hospitalized in [**2095**]
for an asthma exacerbation; prior to that, he was not on any
medications but, during that hospitalization, he required
intubation; the attack was precipitated by an upper
respiratory infection; baseline peak flow is 650.  2.
Eczema; approximately two months ago, required a one month
course of oral Prednisone for treatment of this condition.
3.  Perforated appendicitis.  4.  Mitral valve prolapse.  5.
Seasonal allergies.  6.  Borderline hypertension.

MEDICATIONS ON ADMISSION:  Albuterol meter dose inhaler
p.r.n. and Tylenol p.r.n.

ALLERGIES:  The patient has no known drug allergies.

SOCIAL HISTORY:  The patient does not smoke, drink or use
intravenous drugs.  He is unemployed and lives with his
mother.

FAMILY HISTORY:  There is no family history of asthma or
eczema.

PHYSICAL EXAMINATION:  On physical examination on transfer
from the Medical Intensive Care Unit, the patient had a
temperature of 97.8, blood pressure 140/70, pulse 84,
respiratory rate 24 and oxygen saturation 98% on two liters.
General:  Patient was in no acute distress with only slightly
labored breathing.  Head, eyes, ears, nose and throat:
Oropharynx clear, no lymphadenopathy.  Chest:  Diffuse
inspiratory wheezes bilaterally, no crackles, decreased
breath sounds at bases bilaterally.  Cardiovascular:  Regular
rate and rhythm, no murmurs appreciated.  Abdomen:  Soft,
nontender, nondistended.  Extremities:  No edema.  Skin:
Diffusely hyperpigmented over the face, upper and lower
extremities, and back, flat topped erythematous papules
localized over elbows bilaterally and ankles bilaterally.

LABORATORY DATA:  Admission white blood cell count was 11.5,
hematocrit 40.2, platelet count 248,000, potassium 3.3 and
magnesium 1.8.  Arterial blood gases:  7.38/46/153.  Chest
x-ray showed no infiltrates, no edema.  Blood cultures showed
no growth to date.

HOSPITAL COURSE:  The patient was gradually weaned off of
albuterol nebulizers from every half-hour, every hour, every
two hours to every four hours.  His intravenous steroids were
converted to oral Prednisone and he was subsequently treated
with 60 mg of Prednisone.  At this time, he was transferred
from the Medical Intensive Care Unit to the floor.

While on the floor, the patient maintained oxygen saturations
greater than 94% in room air.  His peak flow on transfer was
approximately 400, down from his baseline of 650.  The
patient was maintained on his Prednisone at 60 mg daily as
well as albuterol nebulizers every four hours.  Beclovent
four puffs twice a day was added at this time.  His
hydrochlorothiazide was discontinued and Dyazide was added at
25 mg daily.

The patient continued to improve.  He received asthma
teaching from the Learning Center.  He remained afebrile with
no nausea or vomiting for the duration of his stay.  He noted
that his breathing became significantly more comfortable and
that he was ready to go home.  The patient was discharged on
[**2101-11-10**], with peak flows in the 500 range.

DISCHARGE MEDICATIONS:
Prednisone taper over a ten day course.
Albuterol nebulizers four puffs q.4-6h.p.r.n.
Beclovent four puffs b.i.d.
Dyazide 25 mg p.o.q.d.

FOLLOW-UP:  The patient was instructed to follow up with Dr.
[**Last Name (STitle) **] in clinic in the next two weeks.  He has been given
the number and will make an appointment at his leisure.




                          [**Name6 (MD) **] [**Name8 (MD) **], M.D.  [**MD Number(1) 4446**]

Dictated By:[**Last Name (NamePattern1) 15679**]

MEDQUIST36

D:  [**2101-11-10**]  14:26
T:  [**2101-11-13**]  10:52
JOB#:  [**Job Number **]
